Special typesGLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) receptor agonistsplay a vital role in controlling appetite, managing blood sugar, and metabolizing fats
Low B12 levels have been associated with depression, cognitive impairment, irritability, and in severe cases, psychosis
Co-infiltration of PP2C-Cluc and SAPK2-Nluc constructs into tobacco leaves generated strong luminescence signals (Fig
Nutritional therapies and herbs both improve GLP-1 activity and in many cases correct the numerous underlying contributors to metabolic dysfunction, through improving insulin sensitivity and satiety, supporting microbiome health and mitigating inflammation that can disrupt metabolic function
Weight Loss The FDA approved GLP-1s to treat type 2 diabetes (T2D) and weight loss in 2005 and 2014, respectively